Page 195 - DMGT401Business Environment
P. 195

Business Environment




                    Notes              be launched within  four months  from the  date of  advertisement of  the acceptance of
                                       complete specification. The Grant of patents could be opposed on the grounds included:

                                       (a)  the invention for which the patent has been claimed was publicly known or publicly
                                            used in India,
                                       (b)  the invention is obvious and does not involve an inventive step,

                                       (c)  the invention is not patentable under the Patent Act 1970,
                                       (d)  the complete specification wrongly mentions the source or geographical origin of
                                            biological material used in the invention, and

                                       (e)  the invention on which the patents is claimed forms part of the traditional knowledge
                                            whether in India or elsewhere.
                                       The 2003 Amendment introduces two sets of changes to the condition relating to opposition
                                       to the grant of patents. First the pre-grant opposition of the 1970 act is proposed to be
                                       changed to a pre-grant representation and secondly  the pre-grant opposition has been
                                       replaced by post-grant opposition. Post Grant opposition, which has been provided in
                                       Section 25(3) of the Patents Act 1970, allows any interested person to oppose the grant of a
                                       patent before the expiry of one year from the date of grant of patent. But while change in
                                       the  system of  opposition has  been included,  the ground  for opposition  has been  left
                                       unchanged. The grounds for pre-grant opposition in the 1970 Act have been retained in the
                                       post-grant opposition of 2003  Amendment and  two sub-clauses (j) and  (k) have been
                                       added.
                                       Pre-grant representation included in Section 25 (I) can be made to the Patent Controller
                                       after the publication of the patent application on the ground of patentability, including
                                       novelty, inventive step and industrial application.


                                          Example: Two other grounds for this representation have been  provided, viz.,  non-
                                   disclosure or wrongful mentioning of the source and geographical origin of biological material
                                   used in the invention and anticipation of the invention by the knowledge, oral or otherwise
                                   available within any local or indigenous community in India or elsewhere.
                                       Section 25(2) says that person making the pre-grant representation cannot be a party to the
                                       proceedings,  which would weaken the  case of those making  the representations.  The
                                       above mentioned implies that  the pre-grant  opposition that  the Patent  Act, 1970  has
                                       provided thus far would be de facto replaced by a post grant opposition.

                                   8.2.2  Salient Features of the Third Amendment to the Patent Law

                                   1.  Extension of product patent protection to all fields of technology (i.e., drugs, food, and
                                       chemicals).
                                   2.  Deletion of the provisions relating to Exclusive Marketing Rights (EMR) and introduction
                                       of a transitional provision for safeguarding EMRs already granted.

                                   3.  Introduction of provision for enabling grant of compulsory licence for export of medicines
                                       to countries that have insufficient or no manufacturing capacity, and to meet emerging
                                       public health situations (in accordance with Doha Declaration on TRIPS and Public Health).
                                   4.  Modification in the provision relating to opposition procedures with a view to streamlining
                                       the system by having both pre-grant and post-grant opposition in the patent office.






          188                               LOVELY PROFESSIONAL UNIVERSITY
   190   191   192   193   194   195   196   197   198   199   200